Search results
Gilead’s Trodelvy extends lung cancer survival by just 1.3 months in trial
WSAU Wausau· 6 days agoBy Deena Beasley (Reuters) - Gilead Sciences' Trodelvy improved survival by 1.3 months more than...
Gilead’s Trodelvy misses goal in bladder cancer study
BioPharma Dive via Yahoo Finance· 6 days agoTreatment didn’t significantly improve overall survival in the trial, a finding that one analyst...
Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer
MedPage Today· 4 days agoThe antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) significantly improved...
Should You Buy the 3 Highest-Yielding Dividend Stocks in the Nasdaq-100?
Motley Fool via Yahoo Finance· 24 hours agoKHC Revenue (TTM) data by YCharts. The final stock on this list is biotech giant Gilead Sciences...
Gilead's Trodelvy fails to meet main goal in late-stage cancer study
Reuters via Yahoo News· 7 days agoShares of Gilead fell 3.3% in extended trade after the company said the drug did not meet the main...
Gilead, with approval in sight, shows $4.3B liver disease drug improves outcomes out to 2 years
FierceBiotech· 1 day agoThe molecule, seladelpar, had already moved the needle in a phase 3 trial by the time Gilead paid...
Gilead's Trodelvy fails to meet main goal in late-stage cancer study
Reuters· 7 days ago, opens new tab said on Thursday its drug Trodelvy, tested in patients with bladder cancer who...
Gilead Sciences Inc London Stock Price Today | NASDAQ 0QYQ Live Ticker - Investing.com
Investing.com· 7 days agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
National Institutes of Health Kickstarts Gilead Sponsored Trials For Twice-Yearly HIV Prevention...
Benzinga via Yahoo Finance· 2 days agoThe mid-stage studies will assess the safety, acceptability, and pharmacokinetics (how a drug moves...
7 Dividend Stocks to Invest In for a Lifetime of Income
InvestorPlace· 1 day agoFinally, the seventh one uses core competencies in financial performance, pipeline innovation, and cancer revenue growth. Without further ado, here are seven dividend stocks to buy to give your ...